Add 2 More Reports For 20% off

Report Overview

2023

Base Year

2017-2023

Historical Year

2024-2032

Forecast Year

Global Xerostomia Treatment Market Outlook

The global xerostomia treatment market is expected to grow at a CAGR of 3.5 % in the forecast period of 2024-2032.

Global Xerostomia Treatment Market

 Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Robust Healthcare System and Awareness Programs in North America to Boost the Market Growth

North America is expected to lead the market for xerostomia treatment, followed by Europe. The major factors governing the market dominance include prominent growth in the number of xerostomia cases as well as other diseases that lead to dry-mouths, such as Sjogren's syndrome, rheumatoid arthritis, and HIV. The large number is also due to the significant geriatric population in these areas. Awareness camps are frequently conducted by various organizations across the US and Canada by the Sjogren's Syndrome Foundation about the disease. Ease of access and availability of healthcare facilities, and robust medical infrastructure with conducive compensation scenarios are some of the important factors, which are helping the market grow in North America. As the Asia-Pacific region is expected to grow at a fast rate during the forecast period, and as healthcare expenditure and awareness about various health conditions improve, the market for xerostomia therapies is expected to grow in these regions. Ailments such as Parkinson’s disease, cancer, diabetes mellitus, are a few of the dry mouth associated diseases. As the awareness of these diseases increases, the market for xerostomia is, in turn, expected to rise over the forecast period.

Xerostomia Treatment: Market Segmentation

Xerostomia, also known as the dry-mouth condition, is a state of lack of saliva production in the mouth. This might also be a consequence of the change in the quality of saliva produced. Normally, it arises due to many different reasons, such as side effects of medicine, dehydration, mouth bleeding, adverse effects of radiation especially due to radiation in surgery, cigarette smoking. Xerostomia is seen as a by-product of other health conditions and is not considered a disease. This condition is majorly observed in the elderly population. Chemotherapy, Sjogren’s Syndrome and HIV are also some of the dry mouth associated diseases.

Global Xerostomia Treatment Market By Distribution CHannel

 Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Based on product, the industry is segmented into:

  • Artificial Saliva
  • Salivary Stimulants
  • Saliva Substitutes
  • Drugs
  • Salivary Pens
  • Others

By type, the industry is bifurcated into:

  • OTC
  • Prescription

On the basis of distribution channels, the industry is segregated into:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online
  • Others

The regional markets for the product include North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

Global Xerostomia Treatment Market By Region

 Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Rising Cases of Lifestyle Diseases to Boost the Market for Xerostomia Treatment

The increasing consumption and dependence on medication is the major driver for the rise of xerostomia treatment industry. A growing number of cases of Sjogren's syndrome as well as diagnosis of it is also a major driver of this market. Moreover, as the geriatric population is increasing across the globe, coupled with increasing cases of chronic and lifestyle related diseases, the market is expected to enhance during the forecast period. There has been a rising awareness towards the diagnosis of xerostomia in recent years is aiding the market growth. This is expected to boost the market growth in the forecast period as well. Further, the increase in the cases of diseases such as cancer, HIV, and Sjogren’s syndrome drives the demand for radiation and chemotherapy. Xerostomia is a side-effect of these treatments. However, lack of health awareness towards xerostomia in developing countries is expected to decelerate the growth of this market.

Key Industry Players in the Global Xerostomia Treatment Market

The report gives a detailed analysis of the following key players in the global xerostomia treatment market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:

  • 3M Co.
  • GlaxoSmithKline plc
  • Saliwell Ltd
  • Sun Pharmaceutical Industries Ltd
  • Cumberland Pharmaceuticals Inc.
  • Others

The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis.

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2023
Historical Period 2017-2023
Forecast Period 2024-2032
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Product
  • Type
  • Distribution Channel
  • Region
Breakup by Product
  • Artificial Saliva
  • Salivary Stimulants
  • Saliva Substitutes
  • Drugs
  • Salivary Pens
  • Others
Breakup by Type
  • OTC
  • Prescription
Breakup by Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online
  • Others
Breakup by Region
  • North America
    • United States of America 
    • Canada
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Others
  • Asia Pacific
    • China
    • Japan
    • India
    • ASEAN
    • Australia
    • Others
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Others
  • Middle East and Africa
    • Saudi Arabia
    • United Arab Emirates
    • Nigeria
    • South Africa
    • Others
Market Dynamics
  • SWOT Analysis
  • Porter's Five Forces Analysis
  • Key Indicators for Demand
  • Key Indicators for Price
Competitive Landscape
  • Market Structure
  • Company Profiles
    • Company Overview
    • Product Portfolio
    • Demographic Reach and Achievements
    • Certifications
Companies Covered
  • 3M Co.
  • GlaxoSmithKline plc
  • Saliwell Ltd
  • Sun Pharmaceutical Industries Ltd
  • Cumberland Pharmaceuticals Inc.
  • Others
Report Price and Purchase Option Explore our purchase options that are best suited to your resources and industry needs.
Delivery Format Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.

*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*

Looking for specific insights?

Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!

Key Questions Answered in the Report

The global xerostomia treatment market is projected to grow at a CAGR of 3.5% between 2024 and 2032.

The major drivers of the market include the rising geriatric population, increasing cases of chronic and lifestyle related diseases, rising awareness towards the diagnosis of xerostomia, increase in the cases of diseases such as cancer, HIV, ease of access and availability of healthcare facilities, and robust medical infrastructure.

The increasing consumption and dependence on medication and a growing number of cases of Sjogren's syndrome as well as its diagnosis are the key industry trends propelling the market's growth.

The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.

The products include artificial saliva, salivary stimulants, saliva substitutes, drugs, and salivary pens, among others.

OTC and prescription are the types of xerostomia treatments.

The xerostomia treatment market can be broadly categorised based on its distribution channels into hospital pharmacies, retail pharmacies, and online, among others.

The major players in the industry are 3M Co., GlaxoSmithKline plc, Saliwell Ltd, Sun Pharmaceutical Industries Ltd, and Cumberland Pharmaceuticals Inc., among others.

Purchase Full Report

Datasheet

 

USD 2,969

USD 2,699

tax inclusive*

  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

One User

USD 5,499

USD 4,999

tax inclusive*

  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

Five Users

USD 6,599

USD 5,999

tax inclusive*

  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

Unlimited Users

USD 7,699

USD 6,999

tax inclusive*

  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

How To Order

Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.

Select License Type

Choose the right license for your needs and access rights.

Click on ‘Buy Now’

Add the report to your cart with one click and proceed to register.

Select Mode of Payment

Choose a payment option for a secure checkout. You will be redirected accordingly.

Strategic Solutions for Informed Decision-Making

Connect For More Information

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.

Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.

We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.

We’re here to help answer any questions about our products and services.

Contact us

Our Offices


Australia

63 Fiona Drive, Tamworth, NSW

+61 448 06 17 27

India

C130 Sector 2 Noida, Uttar Pradesh 201301

+91-858-608-1494

Philippines

40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.

+63 287899028, +63 967 048 3306

United Kingdom

6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London

+44-753-713-2163

United States (Head Office)

30 North Gould Street, Sheridan, WY 82801

+1-415-325-5166

Vietnam

193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City

+84865399124

30 North Gould Street, Sheridan, WY 82801

+1-415-325-5166

63 Fiona Drive, Tamworth, NSW

+61 448 06 17 27

C130 Sector 2 Noida, Uttar Pradesh 201301

+91-858-608-1494

40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.

+63 287899028, +63 967 048 3306

6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London

+44-753-713-2163

193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City

+84865399124